Bladder Cancer - Results from #180

Updated Results of PURE-01 with Preliminary Activity of Neoadjuvant Pembrolizumab in Patients with Muscle-invasive Bladder Carcinoma with Variant Histologies. November 14, 2019

Comparison of Commercial ELISA Kits, a Prototype Multiplex Electrochemoluminescent Assay, and a Multiplex Bead-Based Immunoassay for Detecting a Urine-Based Bladder-Cancer-Associated Diagnostic Signature. November 14, 2019

ACR Appropriateness Criteria® Post-Treatment Surveillance of Bladder Cancer. November 13, 2019

Glycemic impact of a diet and lifestyle intervention on diabetics and prediabetics during treatment for non-muscle invasive bladder cancer. November 13, 2019

Perioperative management of cold agglutinin autoimmune hemolytic anemia in an older adult undergoing radical cystectomy for bladder cancer. November 13, 2019

Cost comparison between open radical cystectomy, laparoscopic radical cystectomy, and robot-assisted radical cystectomy for patients with bladder cancer: a systematic review of segmental costs. November 12, 2019

Systemic immune-inflammation index predicts prognosis of bladder cancer patients after radical cystectomy. November 12, 2019

Patients' self-report anxiety, depression and quality of life and their predictive factors in muscle invasive bladder cancer patients receiving adjuvant chemotherapy. November 12, 2019

Monthly Maintenance Intravesical Combination Gemcitabine/Docetaxel for Non Muscle-invasive Bladder Cancer - Expert Commentary November 11, 2019

Bladder Cancer Outcomes in Women Vary over Time - Expert Commentary November 11, 2019

Outcomes of trimodality bladder-sparing therapy for muscle-invasive bladder cancer. November 11, 2019

Management of non-muscle-invasive bladder cancer: quality of clinical practice guidelines and variations in recommendations. November 11, 2019

Systematic chemical screening identifies disulfiram as a repurposed drug that enhances sensitivity to cisplatin in bladder cancer: a summary of preclinical studies. November 11, 2019

External Replication of Urinary Bladder Cancer Prognostic Polymorphisms in the UK Biobank. November 8, 2019

Screening logs from a pilot randomized controlled trial of radical cystectomy versus chemoradiation therapy for muscle-invasive bladder cancer. November 8, 2019

The prognostic value of the neutrophil-to-lymphocyte ratio in patients with muscle-invasive bladder cancer treated with neoadjuvant chemotherapy and radical cystectomy. November 8, 2019

Long Non-coding RNAs Identify A Subset of Luminal Muscle-invasive Bladder Cancer Patients with Favorable Prognosis November 7, 2019

Prognostic and Clinicopathological Significance of PD-L1 in Patients With Bladder Cancer: A Meta-Analysis. November 7, 2019

Vinflunine/gemcitabine versus carboplatin/gemcitabine as first-line treatment in cisplatin-ineligible patients with advanced urothelial carcinoma: A randomised phase II trial (VINGEM). November 7, 2019

Novel Biomarkers Associated With Progression and Prognosis of Bladder Cancer Identified by Co-expression Analysis. November 6, 2019

Page 10 of 325